Innate immune activation in neurodegenerative disease (original) (raw)

• Kierdorf, K. et al. Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways. Nature Neurosci. 16, 273–280 (2013).
  Article CAS PubMed Google Scholar
• Ginhoux, F. et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330, 841–845 (2010). This paper shows that microglial cell populations originate from the yolk sac and not from the bone marrow, as was previously believed.
  Article CAS PubMed PubMed Central Google Scholar
• Alliot, F., Godin, I. & Pessac, B. Microglia derive from progenitors, originating from the yolk sac, and which proliferate in the brain. Brain Res. Dev. Brain Res. 117, 145–152 (1999).
  Article CAS PubMed Google Scholar
• Lawson, L. J., Perry, V. H., Dri, P. & Gordon, S. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 39, 151–170 (1990).
  Article CAS PubMed Google Scholar
• Parkhurst, C. N. et al. Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor. Cell 155, 1596–1609 (2013). This paper shows that microglia have an important role in learning and memory by generating neurotrophic factors, such as BDNF.
  Article CAS PubMed PubMed Central Google Scholar
• Wake, H., Moorhouse, A. J., Jinno, S., Kohsaka, S. & Nabekura, J. Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J. Neurosci. 29, 3974–3980 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Paolicelli, R. C. et al. Synaptic pruning by microglia is necessary for normal brain development. Science 333, 1456–1458 (2011).
  Article CAS PubMed Google Scholar
• Schafer, D. P. et al. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron 74, 691–705 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Rigato, C., Buckinx, R., Le-Corronc, H., Rigo, J. M. & Legendre, P. Pattern of invasion of the embryonic mouse spinal cord by microglial cells at the time of the onset of functional neuronal networks. Glia 59, 675–695 (2011).
  Article CAS PubMed Google Scholar
• Tremblay, M.-È., Lowery, R. L. & Majewska, A. K. Microglial interactions with synapses are modulated by visual experience. PLoS Biol. 8, e1000527 (2010). This paper shows that microglia direct the shaping of dendritic processes by spine removal in vivo.
  Article CAS PubMed PubMed Central Google Scholar
• Vukovic, J., Colditz, M. J., Blackmore, D. G., Ruitenberg, M. J. & Bartlett, P. F. Microglia modulate hippocampal neural precursor activity in response to exercise and aging. J. Neurosci. 32, 6435–6443 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Fellner, L. et al. Toll-like receptor 4 is required for α-synuclein dependent activation of microglia and astroglia. Glia 61, 349–360 (2013).
  Article PubMed PubMed Central Google Scholar
• Stewart, C. R. et al. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nature Immunol. 11, 155–161 (2010).
  Article CAS Google Scholar
• Udan, M. L. D., Ajit, D., Crouse, N. R. & Nichols, M. R. Toll-like receptors 2 and 4 mediate Aβ(1–42) activation of the innate immune response in a human monocytic cell line. J. Neurochem. 104, 524–533 (2008).
  CAS PubMed Google Scholar
• Jin, J.-J., Kim, H.-D., Maxwell, J. A., Li, L. & Fukuchi, K.-I. Toll-like receptor 4-dependent upregulation of cytokines in a transgenic mouse model of Alzheimer's disease. J. Neuroinflamm. 5, 23 (2008).
  Article CAS Google Scholar
• Latz, E., Xiao, T. S. & Stutz, A. Activation and regulation of the inflammasomes. Nature Rev. Immunol. 13, 397–411 (2013).
  Article CAS Google Scholar
• Strowig, T., Henao-Mejia, J., Elinav, E. & Flavell, R. Inflammasomes in health and disease. Nature 481, 278–286 (2012).
  Article CAS PubMed Google Scholar
• De Rivero Vaccari, J. P. et al. Therapeutic neutralization of the NLRP1 inflammasome reduces the innate immune response and improves histopathology after traumatic brain injury. J. Cereb. Blood Flow Metab. 29, 1251–1261 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Adamczak, S. E. et al. Pyroptotic neuronal cell death mediated by the AIM2 inflammasome. J. Cereb. Blood Flow Metab. 34, 621–629 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Minkiewicz, J., de Rivero Vaccari, J. P. & Keane, R. W. Human astrocytes express a novel NLRP2 inflammasome. Glia 61, 1113–1121 (2013).
  Article PubMed Google Scholar
• Shimohama, S. et al. Activation of NADPH oxidase in Alzheimer's disease brains. Biochem. Biophys. Res. Commun. 273, 5–9 (2000).
  Article CAS PubMed Google Scholar
• Reynolds, W. F. et al. Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease. Exp. Neurol. 155, 31–41 (1999).
  Article CAS PubMed Google Scholar
• Heneka, M. T. et al. Neuronal and glial coexpression of argininosuccinate synthetase and inducible nitric oxide synthase in Alzheimer disease. J. Neuropathol. Exp. Neurol. 60, 906–916 (2001).
  Article CAS PubMed Google Scholar
• Vodovotz, Y. et al. Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease. J. Exp. Med. 184, 1425–1433 (1996).
  Article CAS PubMed Google Scholar
• Monje, M. L., Toda, H. & Palmer, T. D. Inflammatory blockade restores adult hippocampal neurogenesis. Science 302, 1760–1765 (2003).
  Article CAS PubMed Google Scholar
• Nagatsu, T. & Sawada, M. Inflammatory process in Parkinson's disease: role for cytokines. Curr. Pharm. Des. 11, 999–1016 (2005).
  Article CAS PubMed Google Scholar
• Alirezaei, M., Kiosses, W. B., Flynn, C. T., Brady, N. R. & Fox, H. S. Disruption of neuronal autophagy by infected microglia results in neurodegeneration. PLoS ONE 3, e2906 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Koenigsknecht-Talboo, J. & Landreth, G. E. Microglial phagocytosis induced by fibrillar β-amyloid and IgGs are differentially regulated by proinflammatory cytokines. J. Neurosci. 25, 8240–8249 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Sheng, J. G. et al. Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid-β peptide in APPswe transgenic mice. Neurobiol. Dis. 14, 133–145 (2003).
  Article CAS PubMed Google Scholar
• Qiao, X., Cummins, D. J. & Paul, S. M. Neuroinflammation-induced acceleration of amyloid deposition in the APPV717F transgenic mouse. Eur. J. Neurosci. 14, 474–482 (2001).
  Article CAS PubMed Google Scholar
• Jack, C. R. Jr et al. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 12, 207–216 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Querfurth, H. W. & LaFerla, F. M. Alzheimer's disease. N. Engl. J. Med. 362, 329–344 (2010).
  Article CAS PubMed Google Scholar
• Bertram, L., Lill, C. M. & Tanzi, R. E. The genetics of Alzheimer disease: back to the future. Neuron 68, 270–281 (2010).
  Article CAS PubMed Google Scholar
• Mawuenyega, K. G. et al. Decreased clearance of CNS β-amyloid in Alzheimer's disease. Science 330, 1774–1774 (2010). This study provides important evidence that the defective clearance of amyloid-β has a pathogenic role in sporadic Alzheimer's disease.
  Article CAS PubMed PubMed Central Google Scholar
• Breitner, J. C. The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease. Annu. Rev. Med. 47, 401–411 (1996).
  Article CAS PubMed Google Scholar
• Sastre, M. et al. Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-γ agonists modulate immunostimulated processing of amyloid precursor protein through regulation of β-secretase. J. Neurosci. 23, 9796–9804 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Weggen, S. et al. A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity. Nature 414, 212–216 (2001).
  Article CAS PubMed Google Scholar
• in t' Veld, B. A. et al. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N. Engl. J. Med. 345, 1515–1521 (2001).
  Article CAS PubMed Google Scholar
• Iwashyna, T. J., Ely, E. W., Smith, D. M. & Langa, K. M. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA 304, 1787–1794 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Holmes, C. et al. Systemic inflammation and disease progression in Alzheimer disease. Neurology 73, 768–774 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Semmler, A. et al. Persistent cognitive impairment, hippocampal atrophy and EEG changes in sepsis survivors. J. Neurol. Neurosurg. Psychiatr. 84, 62–69 (2012).
  Article Google Scholar
• Whitmer, R. A., Gunderson, E. P., Quesenberry, C. P. Jr, Zhou, J. & Yaffe, K. Body mass index in midlife and risk of Alzheimer disease and vascular dementia. Curr. Alzheimer Res. 4, 103–109 (2007).
  Article CAS PubMed Google Scholar
• Larson, E. B. et al. Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older. Ann. Intern. Med. 144, 73–81 (2006).
  Article PubMed Google Scholar
• Scarmeas, N. et al. Physical activity, diet, and risk of Alzheimer disease. JAMA 302, 627–637 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Kamer, A. R. et al. TNF-α and antibodies to periodontal bacteria discriminate between Alzheimer's disease patients and normal subjects. J. Neuroimmunol. 216, 92–97 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Kamer, A. R. et al. Inflammation and Alzheimer's disease: possible role of periodontal diseases. Alzheimers Dement. 4, 242–250 (2008).
  Article CAS PubMed Google Scholar
• Sparks Stein, P. et al. Serum antibodies to periodontal pathogens are a risk factor for Alzheimer's disease. Alzheimers Dement. 8, 196–203 (2012).
  Article CAS PubMed Google Scholar
• Cagnin, A. et al. In-vivo measurement of activated microglia in dementia. Lancet 358, 461–467 (2001).
  Article CAS PubMed Google Scholar
• Yasuno, F. et al. Increased binding of peripheral benzodiazepine receptor in mild cognitive impairment-dementia converters measured by positron emission tomography with [11C]DAA1106. Psychiatry Res. 203, 67–74 (2012).
  Article CAS PubMed Google Scholar
• Zhang, B. et al. Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease. Cell 153, 707–720 (2013). This study shows that innate immune networks are associated with Alzheimer's disease.
  Article CAS PubMed PubMed Central Google Scholar
• Lambert, J.-C. et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nature Genet. 41, 1094–1099 (2009).
  Article CAS PubMed Google Scholar
• Hollingworth, P. et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nature Genet. 43, 429–435 (2011).
  Article CAS PubMed Google Scholar
• Liang, Y. & Tedder, T. F. Identification of a CD20-, FcɛRIβ-, and HTm4-related gene family: sixteen new MS4A family members expressed in human and mouse. Genomics 72, 119–127 (2001).
  Article CAS PubMed Google Scholar
• Lajaunias, F., Dayer, J.-M. & Chizzolini, C. Constitutive repressor activity of CD33 on human monocytes requires sialic acid recognition and phosphoinositide 3-kinase-mediated intracellular signaling. Eur. J. Immunol. 35, 243–251 (2005).
  Article CAS PubMed Google Scholar
• Bradshaw, E. M. et al. CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology. Nature Neurosci. 16, 848–850 (2013). This paper shows that a single nucleotide polymorphism in the CD33 gene is associated with Alzheimer's disease, and that it leads to altered phagocytosis of amyloid-β fibrils by monocytes and increased levels of amyloid-β in the brains of homozygous carriers.
  Article CAS PubMed Google Scholar
• Griciuc, A. et al. Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron 78, 631–643 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Guerreiro, R. et al. TREM2 variants in Alzheimer's disease. N. Engl. J. Med. 368, 117–127 (2013).
  Article CAS PubMed Google Scholar
• Jonsson, T. et al. Variant of TREM2 associated with the risk of Alzheimer's disease. N. Engl. J. Med. 368, 107–116 (2013). References 57 and 58 link mutations in the gene that encodes the innate immune receptor TREM2 to rare forms of Alzheimer's disease.
  Article CAS PubMed Google Scholar
• Frank, S. et al. TREM2 is upregulated in amyloid plaque-associated microglia in aged APP23 transgenic mice. Glia 56, 1438–1447 (2008).
  Article PubMed Google Scholar
• Melchior, B. et al. Dual induction of TREM2 and tolerance-related transcript, Tmem176b, in amyloid transgenic mice: implications for vaccine-based therapies for Alzheimer's disease. ASN Neuro. 2, e00037 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Bouchon, A., Hernández-Munain, C., Cella, M. & Colonna, M. A. DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells. J. Exp. Med. 194, 1111–1122 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Hamerman, J. A. et al. Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12. J. Immunol. 177, 2051–2055 (2006).
  Article CAS PubMed Google Scholar
• Sheedy, F. J. et al. CD36 coordinates NLRP3 inflammasome activation by facilitating the intracellular nucleation from soluble to particulate ligands in sterile inflammation. Nature Immunol. 14, 812–820 (2013).
  Article CAS Google Scholar
• Chapman, M. R. et al. Role of Escherichia coli curli operons in directing amyloid fiber formation. Science 295, 851–855 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Epstein, E. A. & Chapman, M. R. Polymerizing the fibre between bacteria and host cells: the biogenesis of functional amyloid fibres. Cell. Microbiol. 10, 1413–1420 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Hammer, N. D. et al. The C-terminal repeating units of CsgB direct bacterial functional amyloid nucleation. J. Mol. Biol. 422, 376–389 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Halle, A. et al. The NALP3 inflammasome is involved in the innate immune response to amyloid-β. Nature Immunol. 9, 857–865 (2008). This study shows for the first time that the NLRP3 inflammasome can be activated by fibrillar amyloid-β.
  Article CAS Google Scholar
• Heneka, M. T. et al. NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice. Nature 493, 674–678 (2013). This study shows that NLRP3 activation occurs in microglial cells in the brains of patients with Alzheimer's disease and provides evidence that inhibition of NLRP3 protects neuronal cell function and integrity in vivo.
  Article CAS PubMed Google Scholar
• Tong, L. et al. Brain-derived neurotrophic factor-dependent synaptic plasticity is suppressed by interleukin-1β via p38 mitogen-activated protein kinase. J. Neurosci. 32, 17714–17724 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Cameron, B. et al. Loss of interleukin receptor-associated kinase 4 signaling suppresses amyloid pathology and alters microglial phenotype in a mouse model of Alzheimer's disease. J. Neurosci. 32, 15112–15123 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Davalos, D. et al. ATP mediates rapid microglial response to local brain injury in vivo. Nature Neurosci. 8, 752–758 (2005).
  Article CAS PubMed Google Scholar
• Wu, Z. et al. Differential pathways for interleukin-1β production activated by chromogranin A and amyloid-β in microglia. Neurobiol. Aging 34, 2715–2725 (2013).
  Article CAS PubMed Google Scholar
• Shepherd, C. E. et al. Inflammatory S100A9 and S100A12 proteins in Alzheimer's disease. Neurobiol. Aging 27, 1554–1563 (2006).
  Article CAS PubMed Google Scholar
• Kummer, M. P. et al. Mrp14 deficiency ameliorates amyloid-β burden by increasing microglial phagocytosis and modulation of amyloid precursor protein processing. J. Neurosci. 32, 17824–17829 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Vom Berg, J. et al. Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease-like pathology and cognitive decline. Nature Med. 18, 1812–1819 (2012). This study shows that modulation of the IL-12–IL-23 pathway provides therapeutic benefits in an animal model of cerebral amyloidosis.
  Article CAS PubMed Google Scholar
• Terwel, D. et al. Critical role of astroglial apolipoprotein E and liver X receptor-α expression for microglial Aβ phagocytosis. J. Neurosci. 31, 7049–7059 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Kummer, M. P. et al. Nitration of tyrosine 10 critically enhances amyloid-β aggregation and plaque formation. Neuron 71, 833–844 (2011). This paper links immune activation and the expression of iNOS to the nitration of amyloid-β and the subsequent formation of plaques.
  Article CAS PubMed Google Scholar
• Serrano-Pozo, A., Gómez-Isla, T., Growdon, J. H., Frosch, M. P. & Hyman, B. T. A phenotypic change but not proliferation underlies glial responses in Alzheimer disease. Am. J. Pathol. 182, 2332–2344 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• El Khoury, J. et al. Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nature Med. 13, 432–438 (2007).
  Article CAS PubMed Google Scholar
• Mildner, A. et al. Distinct and non-redundant roles of microglia and myeloid subsets in mouse models of Alzheimer's disease. J. Neurosci. 31, 11159–11171 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Kitazawa, M., Oddo, S., Yamasaki, T. R., Green, K. N. & LaFerla, F. M. Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease. J. Neurosci. 25, 8843–8853 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Lee, C. Y. D. & Landreth, G. E. The role of microglia in amyloid clearance from the AD brain. J. Neural Transm. 117, 949–960 (2010).
  Article CAS PubMed Google Scholar
• Yoshiyama, Y. et al. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 53, 337–351 (2007).
  Article CAS PubMed Google Scholar
• Bhaskar, K. et al. Regulation of tau pathology by the microglial fractalkine receptor. Neuron 68, 19–31 (2010). This study shows that phosphorylation of endogenous mouse tau occurs in response to LPS challenge and that this phenomenon depends on the expression of IL-1 and TLR4 by microglial cells.
  Article CAS PubMed PubMed Central Google Scholar
• Van Langenhove, T., van der Zee, J. & Van Broeckhoven, C. The molecular basis of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum. Ann. Med. 44, 817–828 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Mackenzie, I. R. A. et al. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol. 119, 1–4 (2010).
  Article PubMed Google Scholar
• Sjögren, M., Folkesson, S., Blennow, K. & Tarkowski, E. Increased intrathecal inflammatory activity in frontotemporal dementia: pathophysiological implications. J. Neurol. Neurosurg. Psychiatr. 75, 1107–1111 (2004).
  Article Google Scholar
• Cagnin, A., Rossor, M., Sampson, E. L., Mackinnon, T. & Banati, R. B. In vivo detection of microglial activation in frontotemporal dementia. Ann. Neurol. 56, 894–897 (2004).
  Article PubMed Google Scholar
• Rayaprolu, S. et al. TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease. Mol. Neurodegener. 8, 19 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Baker, M. et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 442, 916–919 (2006).
  Article CAS PubMed Google Scholar
• Petkau, T. L. et al. Progranulin expression in the developing and adult murine brain. J. Comp. Neurol. 518, 3931–3947 (2010).
  Article PubMed Google Scholar
• Chen-Plotkin, A. S. et al. Brain progranulin expression in _GRN_-associated frontotemporal lobar degeneration. Acta Neuropathol. 119, 111–122 (2010).
  Article CAS PubMed Google Scholar
• Kleinberger, G., Capell, A., Haass, C. & Van Broeckhoven, C. Mechanisms of granulin deficiency: lessons from cellular and animal models. Mol. Neurobiol. 47, 337–360 (2013).
  Article CAS PubMed Google Scholar
• Pickford, F. et al. Progranulin is a chemoattractant for microglia and stimulates their endocytic activity. Am. J. Pathol. 178, 284–295 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Martens, L. H. et al. Progranulin deficiency promotes neuroinflammation and neuron loss following toxin-induced injury. J. Clin. Invest. 122, 3955–3959 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Yin, F. et al. Exaggerated inflammation, impaired host defense, and neuropathology in progranulin-deficient mice. J. Exp. Med. 207, 117–128 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Hosler, B. A. et al. Linkage of familial amyotrophic lateral sclerosis with frontotemporal dementia to chromosome 9q21–q22. JAMA 284, 1664–1669 (2000).
  Article CAS PubMed Google Scholar
• Petkau, T. L. et al. Synaptic dysfunction in progranulin-deficient mice. Neurobiol. Dis. 45, 711–722 (2012).
  Article CAS PubMed Google Scholar
• Gerhard, A. et al. [11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy. Neurology 61, 686–689 (2003).
  Article CAS PubMed Google Scholar
• Mogi, M. et al. Interleukin-1β, interleukin-6, epidermal growth factor and transforming growth factor-α are elevated in the brain from parkinsonian patients. Neurosci. Lett. 180, 147–150 (1994).
  Article CAS PubMed Google Scholar
• Damier, P., Hirsch, E. C., Zhang, P., Agid, Y. & Javoy-Agid, F. Glutathione peroxidase, glial cells and Parkinson's disease. Neuroscience 52, 1–6 (1993).
  Article CAS PubMed Google Scholar
• Hirsch, E. C. & Hunot, S. Neuroinflammation in Parkinson's disease: a target for neuroprotection? Lancet Neurol. 8, 382–397 (2009).
  Article CAS PubMed Google Scholar
• Hamza, T. H. et al. Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nature Genet. 42, 781–785 (2010).
  Article CAS PubMed Google Scholar
• International Parkinson Disease Genomics Consortium. Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet 377, 641–649 (2011).
• Noelker, C. et al. Toll like receptor 4 mediates cell death in a mouse MPTP model of Parkinson disease. Sci. Rep. 3, 1393 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• McCoy, M. K. et al. Intranigral lentiviral delivery of dominant negative TNF attenuates neurodegeneration and behavioral deficits in hemiparkinsonian rats. Mol. Ther. 16, 1572–1579 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Zhang, W. et al. Aggregated α-synuclein activates microglia: a process leading to disease progression in Parkinson's disease. FASEB J. 19, 533–542 (2005).
  Article CAS PubMed Google Scholar
• Wu, D.-C. et al. NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. Proc. Natl Acad. Sci. USA 100, 6145–6150 (2003).
  Article CAS PubMed Google Scholar
• Hunot, S. et al. Nitric oxide synthase and neuronal vulnerability in Parkinson's disease. Neuroscience 72, 355–363 (1996).
  Article CAS PubMed Google Scholar
• Giasson, B. I. et al. Oxidative damage linked to neurodegeneration by selective α-synuclein nitration in synucleinopathy lesions. Science 290, 985–989 (2000).
  Article CAS PubMed Google Scholar
• Shavali, S., Combs, C. K. & Ebadi, M. Reactive macrophages increase oxidative stress and alpha-synuclein nitration during death of dopaminergic neuronal cells in co-culture: relevance to Parkinson's disease. Neurochem. Res. 31, 85–94 (2006).
  Article CAS PubMed Google Scholar
• Chung, C. Y. et al. Identification and rescue of α-synuclein toxicity in Parkinson patient-derived neurons. Science 342, 983–987 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Theodore, S., Cao, S., McLean, P. J. & Standaert, D. G. Targeted overexpression of human alpha-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease. J. Neuropathol. Exp. Neurol. 67, 1149–1158 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Harms, A. S. et al. MHCII is required for α-synuclein-induced activation of microglia, CD4 T cell proliferation, and dopaminergic neurodegeneration. J. Neurosci. 33, 9592–9600 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Codolo, G. et al. Triggering of inflammasome by aggregated α-synuclein, an inflammatory response in synucleinopathies. PLoS ONE 8, e55375 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Béraud, D. et al. α-synuclein alters Toll-like receptor expression. Front. Neurosci. 5, 80 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Talbot, K. Motor neurone disease. Postgrad. Med. J. 78, 513–519 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Kawamata, T., Akiyama, H., Yamada, T. & McGeer, P. L. Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am. J. Pathol. 140, 691–707 (1992).
  CAS PubMed PubMed Central Google Scholar
• Frakes, A. E. et al. Microglia induce motor neuron death via the classical NF-κB pathway in amyotrophic lateral sclerosis. Neuron 81, 1009–1023 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Brettschneider, J. et al. Microglial activation correlates with disease progression and upper motor neuron clinical symptoms in amyotrophic lateral sclerosis. PLoS ONE 7, e39216 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Zhao, W. et al. Extracellular mutant SOD1 induces microglial-mediated motoneuron injury. Glia 58, 231–243 (2010).
  Article PubMed PubMed Central Google Scholar
• Boillée, S. et al. Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312, 1389–1392 (2006). This paper shows that microglial cell-restricted deficiency of mutant SOD1 in the SOD G93A mouse model of amyotrophic lateral sclerosis causes prolonged survival in mice, thus proving a role for microglia in disease progression.
  Article CAS PubMed Google Scholar
• Clement, A. M. et al. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 302, 113–117 (2003).
  Article CAS PubMed Google Scholar
• Yamanaka, K. et al. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nature Neurosci. 11, 251–253 (2008).
  Article CAS PubMed Google Scholar
• Meissner, F., Molawi, K. & Zychlinsky, A. Mutant superoxide dismutase 1-induced IL-1β accelerates ALS pathogenesis. Proc. Natl Acad. Sci. USA 107, 13046–13050 (2010).
  Article PubMed Google Scholar
• Iłzecka, J., Stelmasiak, Z. & Dobosz, B. Interleukin-1β converting enzyme/Caspase-1 (ICE/Caspase-1) and soluble APO-1/Fas/CD 95 receptor in amyotrophic lateral sclerosis patients. Acta Neurol. Scand. 103, 255–258 (2001).
  Article PubMed Google Scholar
• Pasinelli, P., Borchelt, D. R., Houseweart, M. K., Cleveland, D. W. & Brown, R. H. Jr. Caspase-1 is activated in neural cells and tissue with amyotrophic lateral sclerosis-associated mutations in copper-zinc superoxide dismutase. Proc. Natl Acad. Sci. USA 95, 15763–15768 (1998).
  Article CAS PubMed Google Scholar
• Han, P. & Whelan, P. J. Tumor necrosis factor alpha enhances glutamatergic transmission onto spinal motoneurons. J. Neurotrauma 27, 287–292 (2010).
  Article PubMed Google Scholar
• Sargsyan, S. A. et al. A comparison of in vitro properties of resting SOD1 transgenic microglia reveals evidence of reduced neuroprotective function. BMC Neurosci. 12, 91 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Nguyen, M. D., D'Aigle, T., Gowing, G., Julien, J.-P. & Rivest, S. Exacerbation of motor neuron disease by chronic stimulation of innate immunity in a mouse model of amyotrophic lateral sclerosis. J. Neurosci. 24, 1340–1349 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Kiaei, M., Kipiani, K., Chen, J., Calingasan, N. Y. & Beal, M. F. Peroxisome proliferator-activated receptor-gamma agonist extends survival in transgenic mouse model of amyotrophic lateral sclerosis. Exp. Neurol. 191, 331–336 (2005).
  Article CAS PubMed Google Scholar
• Schütz, B. et al. The oral antidiabetic pioglitazone protects from neurodegeneration and amyotrophic lateral sclerosis-like symptoms in superoxide dismutase-G93A transgenic mice. J. Neurosci. 25, 7805–7812 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Dupuis, L. et al. A randomized, double blind, placebo-controlled trial of pioglitazone in combination with riluzole in amyotrophic lateral sclerosis. PLoS ONE 7, e37885 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Wilcock, G. K. et al. Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial. Lancet Neurol. 7, 483–493 (2008).
  Article CAS PubMed Google Scholar
• Levine, T. D. et al. A pilot trial of pioglitazone HCl and tretinoin in ALS: cerebrospinal fluid biomarkers to monitor drug efficacy and predict rate of disease progression. Neurol. Res. Int. 2012, 1–6 (2012).
  Article Google Scholar
• Singhrao, S. K., Neal, J. W., Morgan, B. P. & Gasque, P. Increased complement biosynthesis by microglia and complement activation on neurons in Huntington's disease. Exp. Neurol. 159, 362–376 (1999).
  Article CAS PubMed Google Scholar
• Ona, V. O. et al. Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease. Nature 399, 263–267 (1999).
  Article CAS PubMed Google Scholar
• Dalrymple, A. et al. Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates. J. Proteome Res. 6, 2833–2840 (2007).
  Article CAS PubMed Google Scholar
• Björkqvist, M. et al. A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease. J. Exp. Med. 205, 1869–1877 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Silvestroni, A., Faull, R. L. M., Strand, A. D. & Möller, T. Distinct neuroinflammatory profile in post-mortem human Huntington's disease. Neuroreport 20, 1098–1103 (2009).
  Article PubMed Google Scholar
• Tai, Y. F. et al. Microglial activation in presymptomatic Huntington's disease gene carriers. Brain 130, 1759–1766 (2007).
  Article PubMed Google Scholar
• Simmons, D. A. et al. Ferritin accumulation in dystrophic microglia is an early event in the development of Huntington's disease. Glia 55, 1074–1084 (2007).
  Article PubMed Google Scholar
• Crotti, A. et al. Mutant Huntingtin promotes autonomous microglia activation via myeloid lineage-determining factors. Nature Neurosci. 17, 513–521 (2014).
  Article CAS PubMed Google Scholar
• Wild, E. et al. Abnormal peripheral chemokine profile in Huntington's disease. PLoS Curr. 3, RRN1231 (2011).
  Article PubMed PubMed Central Google Scholar
• Crocker, S. F., Costain, W. J. & Robertson, H. A. DNA microarray analysis of striatal gene expression in symptomatic transgenic Huntington's mice (R6/2) reveals neuroinflammation and insulin associations. Brain Res. 1088, 176–186 (2006).
  Article CAS PubMed Google Scholar
• Kraft, A. D., Kaltenbach, L. S., Lo, D. C. & Harry, G. J. Activated microglia proliferate at neurites of mutant huntingtin-expressing neurons. Neurobiol. Aging 33, 621.e17–621.e33 (2012).
  Article CAS Google Scholar
• Kwan, W. et al. Mutant huntingtin impairs immune cell migration in Huntington disease. J. Clin. Invest. 122, 4737–4747 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Khoshnan, A. et al. Activation of the IκB kinase complex and nuclear factor-κB contributes to mutant huntingtin neurotoxicity. J. Neurosci. 24, 7999–8008 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Palazuelos, J. et al. Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity. Brain 132, 3152–3164 (2009).
  Article PubMed Google Scholar
• Bradford, J. et al. Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms. PNAS 106, 22480–22485 (2009).
  Article PubMed Google Scholar
• Shin, J.-Y. et al. Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity. J. Cell Biol. 171, 1001–1012 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Richards, R. I., Samaraweera, S. E., van Eyk, C. L., O'Keefe, L. V. & Suter, C. M. RNA pathogenesis via Toll-like receptor-activated inflammation in expanded repeat neurodegenerative diseases. Front. Mol. Neurosci. 6, 25 (2013).
  Article PubMed PubMed Central Google Scholar
• Samaraweera, S. E., O'Keefe, L. V., Price, G. R., Venter, D. J. & Richards, R. I. Distinct roles for Toll and autophagy pathways in double-stranded RNA toxicity in a Drosophila model of expanded repeat neurodegenerative diseases. Hum. Mol. Genet. 22, 2811–2819 (2013). This study provides the first evidence for a role of dsRNA in mediating the activation of innate immunity in neurodegenerative diseases that are caused by the expansion of variable copy number, tandem repeat sequences.
  Article CAS PubMed PubMed Central Google Scholar
• Shepherd, C. E., Thiel, E., McCann, H., Harding, A. J. & Halliday, G. M. Cortical inflammation in Alzheimer disease but not dementia with Lewy bodies. Arch. Neurol. 57, 817–822 (2000).
  Article CAS PubMed Google Scholar
• Mackenzie, I. R. Activated microglia in dementia with Lewy bodies. Neurology 55, 132–134 (2000).
  Article CAS PubMed Google Scholar
• Katsuse, O., Iseki, E. & Kosaka, K. Immunohistochemical study of the expression of cytokines and nitric oxide synthases in brains of patients with dementia with Lewy bodies. Neuropathology 23, 9–15 (2003).
  Article PubMed Google Scholar
• Rozemuller, A. J., Eikelenboom, P., Theeuwes, J. W., Jansen Steur, E. N. & de Vos, R. A. Activated microglial cells and complement factors are unrelated to cortical Lewy bodies. Acta Neuropathol. 100, 701–708 (2000).
  Article CAS PubMed Google Scholar
• Rüb, U. et al. The nucleus raphe interpositus in spinocerebellar ataxia type 3 (Machado–Joseph disease). J. Chem. Neuroanat. 25, 115–127 (2003).
  Article CAS PubMed Google Scholar
• Petersen, A. J., Rimkus, S. A. & Wassarman, D. A. ATM kinase inhibition in glial cells activates the innate immune response and causes neurodegeneration in Drosophila. Proc. Natl Acad. Sci. USA 109, E656–E664 (2012).
  Article PubMed Google Scholar
• Petersen, A. J., Katzenberger, R. J. & Wassarman, D. A. The innate immune response transcription factor relish is necessary for neurodegeneration in a Drosophila model of ataxia-telangiectasia. Genetics 194, 133–142 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Hsiao, K. et al. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 274, 99–102 (1996).
  Article CAS PubMed Google Scholar
• Jankowsky, J. L. et al. Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. Biomol. Eng. 17, 157–165 (2001).
  Article CAS PubMed Google Scholar
• Jackson-Lewis, V. & Przedborski, S. Protocol for the MPTP mouse model of Parkinson's disease. Nature Protocols 2, 141–151 (2007).
  Article CAS PubMed Google Scholar
• Ungerstedt, U. 6-Hydroxy-dopamine induced degeneration of central monoamine neurons. Eur. J. Pharmacol. 5, 107–110 (1968).
  Article CAS PubMed Google Scholar
• St Martin, J. L. et al. Dopaminergic neuron loss and up-regulation of chaperone protein mRNA induced by targeted over-expression of alpha-synuclein in mouse substantia nigra. J. Neurochem. 100, 1449–1457 (2007).
  CAS PubMed Google Scholar
• Gurney, M. E. et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 264, 1772–1775 (1994).
  Article CAS PubMed Google Scholar
• Wong, P. C. et al. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14, 1105–1116 (1995).
  Article CAS PubMed Google Scholar
• Mangiarini, L. et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493–506 (1996).
  Article CAS PubMed Google Scholar